Relay Therapeutics, Inc. (RLAY) quarterly income statement — complete revenue, gross profit & net income history
Relay Therapeutics, Inc. (RLAY) annual income statement — 8-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 350K | 3M | 7M | 0 | 677K | 7.68M | 0 | 0 | 0 | 10.01M | -1K | 25.2M | 119K | 226K | 253K | 344K | 365K | 419K | 567K |
| Revenue Growth % | - | -48.3% | -60.93% | - | - | - | -23.26% | 100% | -100% | -100% | 4327.88% | -100.4% | 7226.16% | -67.4% | -46.06% | -55.38% | -48.35% | -56.75% | -55.99% | -99.31% |
| Cost of Goods Sold | 0 | 0 | 504K | 599K | 67.89M | 61.47M | 0 | 64.43M | 76.62M | 91.99M | 82.4M | 0 | 81.49M | 88.2M | 82.83M | 63.93M | 66.9M | 60.51M | 51.67M | 51.08M |
| COGS % of Revenue | - | - | 16.8% | 8.56% | - | 9080.06% | - | - | - | - | 823.45% | - | 323.36% | 74118.49% | 36649.11% | 25267.59% | 19447.67% | 16578.36% | 12331.03% | 9008.82% |
| Gross Profit | 0 | 350K | 2.5M | 6.4M | -67.89M | -60.8M | 7.68M | -64.43M | -76.62M | -91.99M | -72.4M | -1K | -56.29M | -88.08M | -82.6M | -63.67M | -66.56M | -60.15M | -51.25M | -50.51M |
| Gross Margin % | - | 100% | 83.2% | 91.44% | - | -8980.06% | 100% | - | - | - | -723.45% | 100% | -223.36% | -74018.49% | -36549.11% | -25167.59% | -19347.67% | -16478.36% | -12231.03% | -8908.82% |
| Gross Profit Growth % | 100% | 100.58% | -67.5% | 109.94% | 11.39% | 33.91% | 110.61% | - | -36.11% | -4.44% | 12.35% | 100% | 15.42% | -46.45% | -61.18% | -26.05% | -53.04% | -35.76% | -72.73% | -161.8% |
| Operating Expenses | 90.25M | 91.17M | 81.09M | 67.03M | 12.5M | 16.05M | 92.55M | 20.55M | 19.75M | 8.77M | 17.97M | 92.19M | 17.29M | 17.97M | 18.58M | 9.18M | 19.34M | 17.66M | 11.47M | 17.21M |
| OpEx % of Revenue | - | 26049.71% | 2702.87% | 957.59% | - | 2371.05% | 1205.21% | - | - | - | 179.54% | -9219500% | 68.59% | 15099.16% | 8219.47% | 3627.27% | 5620.93% | 4839.73% | 2738.19% | 3035.27% |
| Selling, General & Admin | 13.11M | 14.69M | 11.03M | 12.96M | 12.5M | 13.75M | 18.74M | 20.55M | 19.75M | 20.14M | 19.8M | 16.77M | 18.48M | 20.12M | 19.58M | 19.72M | 16.07M | 17.46M | 16.07M | 15.47M |
| SG&A % of Revenue | - | 4197.43% | 367.57% | 185.19% | - | 2031.31% | 244.03% | - | - | - | 197.85% | -1676600% | 73.35% | 16907.56% | 8663.27% | 7794.86% | 4672.67% | 4784.93% | 3834.84% | 2729.1% |
| Research & Development | 77.14M | 76.48M | 70.56M | 55.41M | 68.26M | 63.9M | 73.81M | 68.08M | 76.62M | 91.99M | 82.4M | 77.5M | 81.49M | 88.2M | 82.83M | 67.28M | 66.9M | 60.51M | 51.67M | 51.91M |
| R&D % of Revenue | - | 21852.29% | 2352.1% | 791.64% | - | 9438.26% | 961.18% | - | - | - | 823.45% | -7749600% | 323.36% | 74118.49% | 36649.11% | 26591.7% | 19447.67% | 16578.36% | 12331.03% | 9154.67% |
| Other Operating Expenses | 0 | 0 | -504K | -1000K | -1000K | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -90.25M | -90.82M | -78.59M | -60.63M | -80.39M | -76.85M | -84.87M | -84.98M | -96.37M | -100.76M | -90.36M | -92.2M | -73.58M | -106.05M | -101.18M | -72.85M | -85.89M | -77.81M | -62.72M | -67.72M |
| Operating Margin % | - | -25949.71% | -2619.67% | -866.16% | - | -11351.11% | -1105.21% | - | - | - | -903% | 9219600% | -291.95% | -89117.65% | -44768.58% | -28794.86% | -24968.6% | -21318.08% | -14969.21% | -11944.09% |
| Operating Income Growth % | -12.26% | -18.19% | 7.4% | 28.65% | 16.58% | 23.73% | 6.08% | 7.83% | -30.98% | 4.99% | 10.69% | -26.55% | 14.34% | -36.29% | -61.31% | -7.57% | -40.83% | 59.8% | -47.91% | -293.56% |
| EBITDA | -89.97M | -90.46M | -78.09M | -60.03M | -79.64M | -75.84M | -83.66M | -83.64M | -95M | -99.39M | -88.97M | -90.82M | -72.21M | -104.72M | -99.98M | -71.69M | -84.86M | -76.86M | -61.75M | -66.69M |
| EBITDA Margin % | - | -25846.86% | -2602.87% | -857.6% | - | -11203.1% | -1089.48% | - | - | - | -889.06% | 9082100% | -286.54% | -87996.64% | -44238.94% | -28333.99% | -24668.31% | -21056.16% | -14736.52% | -11761.73% |
| EBITDA Growth % | -12.96% | -19.27% | 6.66% | 28.23% | 16.17% | 23.69% | 5.97% | 7.9% | -31.56% | 5.09% | 11.01% | -26.69% | 14.9% | -36.25% | -61.92% | -7.49% | -41.48% | 60.1% | -48.84% | -285.76% |
| D&A (Non-Cash Add-back) | 280K | 360K | 504K | 599K | 748K | 1M | 1.21M | 1.33M | 1.37M | 1.37M | 1.4M | 1.38M | 1.36M | 1.33M | 1.2M | 1.17M | 1.03M | 956K | 975K | 1.03M |
| EBIT | -81.75M | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M | -77.06M | -76M | -88.11M | -112.13M | -92.19M | -94.26M | -74.78M | -108.2M | -102.18M | -83.39M | -82.63M | -77.61M | -67.32M | -65.99M |
| Net Interest Income | 8.5M | 7.12M | 5.35M | 5.71M | 6.41M | 7.11M | 7.81M | 8.97M | 8.27M | 8.55M | 8.95M | 8.7M | 7.84M | 7.56M | 6.94M | 5.37M | 1.71M | 1M | 696K | 267K |
| Interest Income | 8.5M | 7.12M | 5.35M | 5.71M | 6.41M | 7.11M | 7.81M | 8.97M | 8.27M | 8.55M | 8.95M | 8.7M | 7.84M | 7.56M | 6.94M | 5.37M | 1.71M | 1M | 696K | 267K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 8.5M | 7.12M | 5.3M | 5.74M | 6.24M | 6.47M | 7.8M | 8.97M | 8.26M | 8.54M | 8.98M | 8.7M | 7.84M | 7.54M | 6.94M | 5.35M | 1.72M | 1.02M | 675K | 267K |
| Pretax Income | -81.75M | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M | -77.06M | -76M | -88.11M | -92.21M | -81.39M | -83.5M | -65.73M | -98.5M | -94.24M | -67.5M | -84.17M | -76.79M | -62.05M | -67.46M |
| Pretax Margin % | - | -23916.29% | -2443.03% | -784.14% | - | -10395.13% | -1003.58% | - | - | - | -813.3% | 8349500% | -260.83% | -82777.31% | -41698.67% | -26681.03% | -24468.6% | -21037.81% | -14808.11% | -11897% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -81.75M | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M | -77.06M | -76M | -88.11M | -92.21M | -81.39M | -83.5M | -65.73M | -98.5M | -94.24M | -67.5M | -84.17M | -76.79M | -62.05M | -67.46M |
| Net Margin % | - | -23916.29% | -2443.03% | -784.14% | - | -10395.13% | -1003.58% | - | - | - | -813.3% | 8349500% | -260.83% | -82777.31% | -41698.67% | -26681.03% | -24468.6% | -21037.81% | -14808.11% | -11897% |
| Net Income Growth % | -10.24% | -18.94% | 4.9% | 27.78% | 15.84% | 23.68% | 5.31% | 8.97% | -34.03% | 6.39% | 13.64% | -23.69% | 21.91% | -28.28% | -51.89% | -0.07% | -38.37% | 60.3% | -47.08% | -291.22% |
| Net Income (Continuing) | -81.75M | -83.71M | -73.29M | -54.89M | -74.15M | -70.38M | -77.06M | -76M | -88.11M | -92.21M | -81.39M | -83.5M | -65.73M | -98.5M | -94.24M | -67.5M | -84.17M | -76.79M | -62.05M | -67.46M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.37 | -0.41 | -0.41 | -0.32 | -0.43 | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 |
| EPS Growth % | 13.95% | 0% | 10.87% | 28.89% | 31.75% | 40.58% | 25.81% | 33.82% | -16.67% | 14.81% | 13.89% | -88.89% | 31.65% | -14.08% | -50% | 45.45% | -19.7% | 66.19% | -2.13% | -232% |
| EPS (Basic) | -0.37 | -0.41 | -0.41 | -0.32 | -0.43 | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 |
| Diluted Shares Outstanding | 219.16M | 202.85M | 179.85M | 171.59M | 172.39M | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M |
| Basic Shares Outstanding | 219.16M | 202.85M | 179.85M | 171.59M | 172.39M | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |